Synthetic consortia of nanobody‐coupled and formatted bacteria for prophylaxis and therapy interventions targeting microbiome dysbiosis‐associated diseases and co‐morbidities

Designed nanobody‐linked synthetic consortia for microbiota dysbiosis therapies. A. Nanobodies (Nb) are selected for specific antigens on target bacteria destined for a synthetic therapy consortium that may consist of two (B) or multiple (C) members. For the treatment of dysbiosis co‐morbidities req...

Descripción completa

Detalles Bibliográficos
Autores principales: Timmis, Kenneth, Timmis, James Kenneth, Brüssow, Harald, Fernández, Luis Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Crystal Ball
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302794/
https://www.ncbi.nlm.nih.gov/pubmed/30575298
http://dx.doi.org/10.1111/1751-7915.13355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302794/
https://www.ncbi.nlm.nih.gov/pubmed/30575298
http://dx.doi.org/10.1111/1751-7915.13355

Ejemplares similares